A. H. Corner

One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients

Mathijs C. Bunck, Michaëla Diamant, A. H. Corner et al. · Diabetes Care · 2009 · 385 citations · Full text

Effects of Exenatide on Measures of β-Cell Function After 3 Years in Metformin-Treated Patients With Type 2 Diabetes

Mathijs C. Bunck, A. H. Corner, Björn Eliasson et al. · Diabetes Care · 2011 · 237 citations · Full text

Liver Fat Is Increased in Type 2 Diabetic Patients and Underestimated by Serum Alanine Aminotransferase Compared With Equally Obese Nondiabetic Subjects

Anna Kotronen, Leena Juurinen, Antti Hakkarainen et al. · Diabetes Care · 2007 · 198 citations

Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

Mathijs C. Bunck, Michaëla Diamant, Björn Eliasson et al. · Diabetes Care · 2010 · 155 citations · Full text

One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress

Mathijs C. Bunck, A. H. Corner, Björn Eliasson et al. · Atherosclerosis · 2010 · 133 citations

Obesity, Metabolic Syndrome, Diabetes Management +12